Providing Strong Support and Innovation in Oncology
CMIC Group’s specialized oncology staff assists with strategic development planning, including regulatory interaction, conducting clinical studies and post-marketing promotion for companies that wish to enter into the field of oncology. Our resources, with an established network of Key Opinion Leaders (KOLs) in hematologic malignancies and solid tumors, will benefit your oncology project from development to marketing.
Our Edge in Oncology
Highly specialized oncology expertise
- Our team has average 10+ years of oncology experience and strong relationships with KOLs in Japan and Asia, allowing them to be on top of oncology trends. Our specialists have experiences of various study designs both of selected population and broad range of population.
- Experience with gene therapy, immune therapy or biologic treatment studies and geographic experience, covering a wide range: from rare cancers to population-based cancers.
Joint research on blood cancer with National Cancer Center Japan
- In 2020, CMIC and the National Cancer Center Japan (NCC) signed joint research agreement regarding the use of data on cancer-related gene mutations in hematologic malignancies. Click Here for more details.
Experience of Different Cancers
Hematologic Malignancies | Solid Tumor |
Myelodysplastic syndrome | All solid cancers (all comers) |
Primary Myelofibrosis | Non-small cell lung cancer |
Chronic Myeloid Leukemia | Small cell lung cancer |
Acute Myeloid Leukemia | Gastrointestinal stromal tumor |
Ph-positive subtype of active lymphatic leukemia | Stomach cancer |
Multiple myeloma | Hepatocellular carcinoma |
Mature T-cell Lymphoma | Pancreatic cancer |
Mature B-cell Lymphoma | Colon cancer |
Hodgkin’s Lymphoma | Prostate cancer |
Breast cancer | |
Biliary tract cancer | |
Ovarian cancer | |
Mesothelioma | |
Melanoma | |
Glioma | |
Cancer of Unknown Primary |
End-to-end Solution of CMIC Oncolgy
Consulting Services
- Strategic development planning and consultation
- Regulatory authority consultation leadership and support
- Formulation of strategic development plans
- Optimized study design
- Consulting Services
- Japan Market Entry / IPM (Innovative Pharma Model)
Clinical Trial Services
- Project Management
- Clinical Operation
- Data Management
- Pharmacovigilance
- Quality Assurance
- Statistical Analysis
- Medical Writing
Site and Patient Support
- Patient recruitment and retention
- Clinical Research Coordinator (CRC) services
- Clinical site administration support
- Healthcare website (HelC) with oncology clinical trial information